Document is current
Any future updates will be listed below
-
Authors
Zimmermann, Heiner
Koenecke, Christian http://orcid.org/0000-0001-7025-1735
Dreyling, Martin H.
Pott, Christiane
Dührsen, Ulrich http://orcid.org/0000-0002-4034-9472
Hahn, Dennis
Meidenbauer, Norbert
Hauser, Ingeborg A.
Rummel, Mathias J.
Wolf, Dominik
Heuser, Michael http://orcid.org/0000-0001-5318-9044
Schmidt, Christian
Schlattmann, Peter
Ritgen, Matthias
Siebert, Reiner http://orcid.org/0000-0001-7433-3703
Oschlies, Ilske http://orcid.org/0000-0002-4003-6855
Anagnostopoulos, Ioannis
Trappe, Ralf U. http://orcid.org/0000-0001-7565-7160
-
Funding
Funding for this research was provided by:
Roche
- License Information
-
More Information
Article History
Received: 12 June 2022
Revised: 18 July 2022
Accepted: 22 July 2022
First Online: 16 August 2022
Competing interests
: HZ received grant support from ATARA, and other non-financial support from ATARA and Janssen, all outside the submitted work. MHD received grant support and personal fees from Roche, all outside the submitted work. UD received grant support from Celgene and personal fees from Amgen and Celltex Patient Treatment, all outside the submitted work. DH received grants from Abbvie, Astellas, Bayer, BerGenBio, BMS, Daiichi Sankyo, Jazz Pharmaceuticals, Novartis, Pfizer and Roche, personal fees from Abbvie, Eurocept, Jannsen, Jazz Pharmaceuticals, Novartis and Takeda, and other non-financial support from Abbvie, Agios, BMS, Daiichi Sankyo, Jazz Pharmaceuticals, Kura Oncology, Pfizer, PinotBio, Roche and Tolremo, all outside the submitted work. IAH received personal fees from Astellas, Biotest, CareDx Inc., MSD, Novartis, Takeda and Teva, all outside the submitted work. CS received personal fees from BMS, Gliead, Janssen and Novartis and non-financial support from BMS, Gliead, Jannsen, Novartis and Roche, all outside the submitted work. PS received grants from the German research foundation and the German Ministry for Education and Research, all outside the submitted work. MR received personal fees from Abbvie, AstraZeneca, Jannsen, MSD and Roche, all outside the submitted work. NM received non-financial support from GlaxoSmithKline, PharmaMar and Jannsen, all outside the submitted work. RS received grant support from the German Cancer Aid, the German Research Foundation, KKI Buchholz/Holm Seppensen, the BW Foundation and the German Ministry for Education and Research, and personal fees from AstraZeneca, all outside the submitted work. RUT received grant support from Roche during the conduct of the study; grant support from Roche and ATARA, personal fees from Abbvie and ATARA, and other non-financial support from Abbvie, ATARA, Celgene, Janssen and Roche, all outside the submitted work. All other authors declared no conflicts of interest.
